Metro Pharma Phils., Inc.

A Philippine-based search and development company engaged in the ethical and consumer marketing of top quality pharmaceutical and nutraceutical products that provide innovative solutions to the current healthcare needs of the Filipino. MPPI was first established as a division of Metro Drug by the Metro Pacific Group (Phil. subsidiary of First Pacific Co. Ltd.) In 1991, it was spun-off as a separate corporation set up to provide third party service marketing to its multinational principals. MPPI’s success was achieved based on its market-driven strategies and sensitivities. This direction is pursued relentlessly by a committed management team and highly motivated sales force.

Dyna Drug Corporation

Dyna Drug Corporation is the leading wholesaler, distributor, and importer of pharmaceutical, cosmetic, and consumer goods in the Philippines, recognized for its commitment to serving independent drugstores. We specialize in the wholesale distribution of these products, meticulously sourcing the highest quality, FDA-approved items from trusted principals. Our comprehensive services include rigorous quality assurance inspections and evaluations, ensuring that only the best products reach our customers. We pride ourselves on offering a diverse assortment of goods, tailored to meet the unique needs of our consumers. As a key distributor, Dyna Drug leverages an extensive countrywide network and robust infrastructure to efficiently procure, store, and distribute products. Our dedication to excellence is evident in our adherence to FDA standards and WHO’s Good Storage and Distribution Practices (GSDP). We maintain optimal storage conditions to preserve product integrity and regularly train our employees on GSDP to uphold these standards. Since achieving ISO 9001:2015 certification in 2021, we have continued to enhance our operations, reflecting our unwavering commitment to quality and customer satisfaction. At Dyna Drug, we not only supply renowned drugstores but also ensure that thousands of independent drugstores, hospitals, and modern trade outlets across the Philippines have access to top-quality products. Dyna Drug is chosen by pharmacies, chain drugstores, and other wholesalers and sub-distributors for our reliability and dedication to advancing healthcare through quality and excellence.

servier philippines

Servier is a global pharmaceutical group governed by a nonprofit foundation, committed to making a meaningful social impact for patients and contributing to a sustainable world. The Group’s unique governance model ensures its independence while fostering long-term innovation, with 100% of its profits reinvested in the company’s development. As a world leader in cardiometabolism and venous diseases, Servier drives transformative innovation in chronic conditions through a holistic approach, making patient adherence a priority across the globe. Its ambition is to become a leading player in rare cancers, which is why the Group invests heavily in oncology, allocating close to 70% of its R&D budget to this field. By leveraging precision medicine, Servier develops therapies that are more targeted and more effective. Bolstered by its success in oncology, Servier has expanded into neurology, a key driver of future growth. The Group focuses on a select number of neurodegenerative diseases, where accurate patient profiling enables targeted therapeutic responses through precision medicine. To further enhance access to high-quality, affordable care, Servier also provides an extensive range of generic medicines, building on well-established brands in France, Eastern Europe, and Brazil. In all its activities and at every stage of the medicine life cycle, the Group integrates the patient’s voice. Headquartered in France, Servier operates in close to 140 countries. In 2023-2024, the Group, which employs over 22,000 people worldwide, achieved sales revenue of €5.9 billion. To report a suspected adverse event with a Servier drug, please visit https://servier.com.ph/contact-us/#report-a-side-effect

faberco life sciences inc.

Faberco Life Sciences Inc. (FLS), a Philippine biopharmaceutical organization, is focused on providing innovative, highly niche pharmaceutical products to both public and private health sectors. Faberco partners with reputable international manufacturers who target product platforms and therapeutic categories to treat and prevent diseases which are of public health concern. Pursuing a passion for excellence in operations and services ensures access to premium quality yet affordable products that meet national and international regulatory standards. Our team consists of competent and experienced members with expertise in public health, market research, sales and distribution, medical affairs, financial and operational management. The organization operates on an end-to-end ERP system, that includes an automated warehouse and logistics management system with the capacity to expand business growth and enable quick and efficient order fulfilment for customer satisfaction. Our current product lines consist of the following therapeutic categories, Antiretroviral drugs (ARVs for HIV), Vaccines, Hormonal Contraceptives, Diagnostic Imaging, and Respiratory Care. Future extensions will also include Neurology, Psychiatric and Substance Disorder, Addiction, Pain Management, Oncology and Immunosuppressive products, Critical Care products, Screening Tests.

aspen philippines inc.